MINNEAPOLIS — Medtronic is weighing its next steps after losing another round in a long-running patent dispute with med-tech competitor Teleflex Inc.
Teleflex has maintained that Medtronic violated its patents in 2019 with its product Telescope on its GuideLiner extension catheter technology originally developed in Maple Grove.
Medtronic challenged some of the patents and appealed an earlier decision by the U.S. Patent and Trademark Patent Trial and Appeal Board that sided with Teleflex. The U.S. Court of Appeals for the Federal Circuit last week sided with the Patent Appeal Board.